tiprankstipranks
Trending News
More News >

Per Wold-Olsen Insider Profile

4 Followers
Per Wold-Olsen, Director at Oncopeptides AB, holds 1.50M shares in Oncopeptides AB (Ticker: SE:ONCO), holds 55.13K shares in GN Store Nord (Ticker: GB:0K9P), holds 171.03K shares in Amarin (Ticker: AMRN).
tipranks
Per Wold-Olsen

Per Wold-Olsen
Oncopeptides AB (ONCO)
Director

Ranked #99,249 out of 105,219 Corporate Insiders

Profitable Transactions

29%
8 out of 28 Profitable Transactions

Average Return

-22.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$4M
46.32%
38.16%
15.52%
A breakdown of Per Wold-Olsen's holdings

Insider Roles

Oncopeptides AB
(ONCO)
Director
GN Store Nord
(0K9P)
Director
Amarin
(AMRN)
Director
Roles that Per Wold-Olsen holds in companies

Most Profitable Insider Trade

Stock:
Oncopeptides AB
(ONCO)
Rating:Informative Buy
Date:May 22, 2018 - May 22, 2019
Return:+35.90%
The most profitable trade made by Per Wold-Olsen

Per Wold-Olsen's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Oncopeptides AB
Oct 17, 2025
Director
Uninformative Buy
kr7.06M
GN Store Nord
Sep 01, 2022
Director
Informative Buy
505.50K
kr5.82M
Amarin
Director
$2.37M
List of latest transactions for each holding click on a transaction to see Per Wold-Olsen's performance on stock

Per Wold-Olsen insider profile FAQ

What is the percentage of profitable transactions made by Per Wold-Olsen?
The percentage of profitable transactions made by Per Wold-Olsen is 29%.
    What is the average return per transaction made by Per Wold-Olsen?
    The average return per transaction made by Per Wold-Olsen is -22.10%.
      What stocks does Per Wold-Olsen hold?
      Per Wold-Olsen holds: SE:ONCO, GB:0K9P, AMRN stocks.
        What was Per Wold-Olsen’s latest transaction?
        Per Wold-Olsen latest transaction was an Uninformative Buy of ―.
          What was Per Wold-Olsen's most profitable transaction?
          Per Wold-Olsen’s most profitable transaction was an Informative Buy of SE:ONCO stock on May 22, 2018. The return on the trade was 35.90%.
            What is Per Wold-Olsen's role in Oncopeptides AB?
            Per Wold-Olsen's role in Oncopeptides AB is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.